BABA vs DMAC · P/E 20, rev $137.30B vs $157.4M cap
Alibaba Group Holding Ltd (BABA) versus DiaMedica Therapeutics Inc (DMAC) — a side-by-side from cached financials, not a winner call.
Alibaba Group Holding Ltd (BABA) is a internet retail company listed on US.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Latest reported BABA revenue for 2025-03-31 was $137.30B. Net income was $17.93B. Revenue was up 5.3% from 2024-03-31 to 2025-03-31. BABA currently screens at market cap $305.19B and trailing P/E 19.6.
DMAC does not have a complete income-statement cache yet.
BABA currently screens at market cap $305.19B and trailing P/E 19.6. DMAC currently screens at market cap $157.4M.
Not investment advice. Open the BABA and DMAC stock pages for the full models.
Not investment advice.